Medications within dermatology     

FOI REFERENCE: 24340  FOI DATE: 3^rd September 2024      

How many patients were treated in August 2024 (or latest available month) by the Dermatology department with the following drugs:

• Abrocitinib (Cibinqo)                           0
• Baricitinib (Olumiant)                          0
• Dupilumab (Dupixent)                        18
• Lebrikizumab (Ebglyss)                      0
• Omalizumab (Xolair)                           *
• Tralokinumab (Adtralza)                     *
• Upadacitinib (Rinvoq)                         0